Skip to main content

Proliferating Geriatric Population: Major Driver for the Global Patient Engagement Solutions Market


The geriatric population is the major end user segment of healthcare services. Involvement of geriatric population is significant in healthcare decision making and wellness activities. The rising geriatric population is driving the market growth for patient engagement solutions. According to World Health Organization, in 2017, the global population aged 60 years or more was 962 million, that was more than twice of the same in 1980. The geriatric population is expected to double and reach up to 2.1 billion in 2050.



The strategies followed by several companies to increase their market dominance may vary from product launches to strategic partnerships, collaborations, and agreements. Besides, on tracking and analyzing the significant developments witnessed in the market for the past three years (February 2016- June 2019), it has been observed that majority of the players in the market prefer partnerships, mergers and acquisitions to further expand the business, while the relatively less adopted strategies comprised expansion and agreement. In the past four years (February 2016-June 2019), the market witnessed approximately 78 partnerships, 15 acquisitions, eight collaborations, 22 launches, three agreements, four awards, two funding, three business expansions, and two mergers.

As per BIS Research study, the global patient engagement solutions market is projected to grow at a significant CAGR of 14.09% during the forecast period, 2019-2028.

This work has been designed to answer some of the most crucial questions of the global patient engagement solution market:
§  What are the major market drivers, challenges, and opportunities in the global patient engagement solution market?
§  What is the global patient engagement solution market size in terms of revenue in the period 2016-2028?
§  How is each segment of the global patient engagement solution market expected to grow during the forecast period and what is the revenue expected to be generated by each of the segments by the end of 2028?
§  What are the key development strategies implemented by the key major players to sustain in the competitive market?
§  What is the growth potential of the patient engagement solution market in each region, namely North America, Europe, Asia-Pacific, and the Rest-of-the-World?
§  What components (software and services) are offered by key players such as IBM Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Cisco, and Cerner Corporation?

Labels:

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more

Agriculture Technology-as-a-Service Market Research, Trends and Forecast To 2026

As agriculture becomes a lucrative high-technology industry, professionals with new-age skill sets, companies, and investing bodies are being drawn in rapidly.  The development in smart agriculture technologies has not only led to advancements in the production capabilities of farmers but has also introduced transformative business models in the industry. Report Overview is Available at: https://bisresearch.com/industry-report/agriculture-technology-service-market-report.html As the entire agriculture industry incorporates and experiences the growth of these agriculture technologies into the farming cycle, it also faces the challenges associated with its adoption. One of the major restraining factors associated with the adoption is the large capital investments required for its acquisition and operation. Most of the farming communities across the world do not have a strong financial background to execute significant capital formation. Since prices for technologically advanced farm ...
Post a Comment
Read more